Uğuz Aysun, Gönlüşen Gülfiliz, Ergin Melek, Tuncer Ilhan
Cukurova University, Faculty of Medicine, Department of Pathology, Adana, Turkey.
Nephrology (Carlton). 2005 Jun;10(3):311-6. doi: 10.1111/j.1440-1797.2005.00397.x.
Apoptosis plays a crucial role in glomerulonephritis (GN) as a regulatory mechanism and is controlled by various molecules including Fas antigen, Bcl-2 and p53 oncoproteins. The aim of the present study is to evaluate the correlation between the expression of these molecules and clinical and laboratory data in different types of GN.
The expression of Fas antigen, Bcl-2 and p53 protein in five normal human kidney specimens and 55 tissues from patients with several types of GN were examined by immunohistochemistry and correlated with clinical and laboratory findings. The number of Fas-positive intraglomerular cells was significantly increased in proliferative GN when compared with non-proliferative cases. Numbers of Bcl-2- and p53-positive cells in proliferative GN were not different from the non-proliferative cases and there was no correlation between the changes in Fas, Bcl-2 and p53 themselves. Significant correlation of expression of these molecules with clinical and laboratory findings was not found, except between p53 and blood urea nitrogen levels.
Apoptosis is a complex molecular process and the results of the present study should be supported with other methods to understand whether apoptosis contributes to progression or resolution of GN. Increased glomerular expression of Fas, Bcl-2 and p53 molecules in all types of GN might contribute new therapeutic approaches by modulating the expression of these molecules.
细胞凋亡作为一种调节机制在肾小球肾炎(GN)中发挥着关键作用,并且受包括Fas抗原、Bcl-2和p53癌蛋白在内的多种分子调控。本研究旨在评估这些分子的表达与不同类型GN的临床及实验室数据之间的相关性。
采用免疫组织化学方法检测了5例正常人肾标本以及55例不同类型GN患者组织中Fas抗原、Bcl-2和p53蛋白的表达,并将其与临床及实验室检查结果进行相关性分析。与非增殖性GN病例相比,增殖性GN中Fas阳性肾小球内细胞数量显著增加。增殖性GN中Bcl-2和p53阳性细胞数量与非增殖性病例无差异,且Fas、Bcl-2和p53自身变化之间无相关性。除p53与血尿素氮水平之间外,未发现这些分子的表达与临床及实验室检查结果存在显著相关性。
细胞凋亡是一个复杂的分子过程,本研究结果应通过其他方法加以佐证,以明确细胞凋亡是否促进GN的进展或缓解。各类GN中肾小球Fas、Bcl-2和p53分子表达增加可能通过调节这些分子的表达为新的治疗方法提供思路。